InnerScope Hearing Technologies, Inc. — Cyborg Score 2/10
Challenged
Hearing Aid Manufacturing and Distribution
Strategic Profile
InnerScope is focused on leveraging strategic assets to identify, incubate, and support health-technology ventures positioned for growth in public markets and long-term shareholder value creation. The company operates as a micro-cap OTC-listed entity with minimal market capitalization and extremely limited liquidity.
Cyborg Score Rationale
As of June 27, 2026, InnerScope's shares are valued at $0.11 with a market cap of approximately $518K. The company shows severe operational and financial challenges with minimal revenue, negligible trading volume, and significant stock price volatility. The business model pivoted from advertising to hearing aids in 2017, but has failed to achieve meaningful scale.
Top Insights
Penny stock status with market cap under $1M as of June 2026, reflecting extreme distress and minimal investor confidence
Pivoted from advertising to hearing aids in 2017 but has generated negligible revenue growth since transformation
Only 4 total employees, indicating minimal operational scale and execution capability
OTC-quoted with average daily volume of 37.62K shares, indicating very thin liquidity and high trading friction
Named Competitors
Hearing Aid Devices — Leading hearing aid manufacturer and distributor
Hearing Solutions — Global hearing care and communication devices
ReSound Hearing Aids — Hearing aid and audio communications devices
Recent Developments
(April 2026) Stock price trading between $0.0004-$0.0005 per share with minimal trading activity
(June 2026) Market capitalization approximately $518K based on $0.11 share price
Open the full interactive InnerScope Hearing Technologies, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.